Peptide receptor radionuclide therapy during the COVID-19 pandemic: Are there any concerns? Correspondence

   

Authors:	Bodei, L.; Bergsland, E.; de Herder, W. W.; Ferone, D.; Hicks, R. J.; Hope, T. A.; Kunikowska, J.; Pavel, M.; Reidy-Lagunes, D.; Siveke, J.; Strosberg, J.; Dittmer, U.; Herrmann, K.
Title:	Peptide receptor radionuclide therapy during the COVID-19 pandemic: Are there any concerns?
Keywords:	mortality; metabolism; radiotherapy; risk factors; risk factor; lymphocytopenia; nuclear medicine; receptor; lymphopenia; virus pneumonia; adverse event; complication; pandemic; receptors, peptide; pneumonia, viral; humans; human; coronavirus infections; coronavirus infection; pandemics
Journal Title:	Journal of Nuclear Medicine
Volume:	61
Issue:	8
ISSN:	0161-5505
Publisher:	Society of Nuclear Medicine
Date Published:	2020-08-01
Start Page:	1094
End Page:	1095
Language:	English
DOI:	10.2967/jnumed.120.249136
PUBMED:	32576637
PROVIDER:	scopus
PMCID:	PMC7413236
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089126063&doi=10.2967%2fjnumed.120.249136&partnerID=40&md5=0088c9ab3578deea55a99e3a0dda1263
Notes:	Letter -- Export Date: 1 September 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169806